Comparative efficacy of three dry-cow antibiotic formulations in springcalving New Zealand dairy cows

New Zealand Veterinary Journal

Volumn 48, Issue 5, 2000, Pages 129-135

  Parkinson, T J ^a   Vermunt, J J ^a   Merrall, M ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

Cephalonium; Cloxacillin; Cloxacillin plus ampicillin; Dairy cow; Dry period; Mastitis; Somatic cell counts

Indexed keywords

EID: 0034287792     PISSN: 00480169     EISSN: 11760710     Source Type: Journal    
DOI: 10.1080/00480169.2000.36179     Document Type: Article

References (38)

1. Barkema HW, Schukken YH, Lam TJGM, Galligan DT, Beiboer ML, Brand A. Estimation of interdependence among quarters of the bovine udder with subclinical mastitis and implications for analysis. Journal of Dairy Science 80, 1592–9, 1997.
2. Belton D. Antibiotic sensitivity of mastitis pathogens. Surveillance 18(2), 8, 1991.
3. Bramley, AJ. Mastitis and machine milking. In:Bramley AJ, Dodd FH, Mein GA (eds). Machine Milking and Lactation. Pp 343–72. Insight Books, Newbury, United Kingdom, 1992.
4. Browning JW, Mein GA, Brightling P, Nicholls TJ, Barton M. Strategies for mastitis control:dry cow therapy and culling. Australian Veterinary Journal 71, 179–81, 1994.
5. Buddle BM, Cooper MG. Aspects of the epidemiology of bovine staphylococcal mastitis. New Zealand Veterinary Journal 26, 296–8, 1978.
6. Cantor A, Palochak M. The in vitro sensitivity of antibiotic-resistant bacteria to intramammary preparations. Veterinary Medicine and Small Animal Clinician, 70, 800–8, 1975.
7. Clegg FG, Halliday GJ, Hardie H. Dry-cow therapy:a comparative field trial using benzathine cloxacillin and erythromycin. British Veterinary Journal 131, 639–42, 1975.
8. Craven N, Anderson JC, Jones TO. Antimicrobial drug susceptibility of Staphylococcus aureus isolated from bovine mastitis. Veterinary Record 118, 290–1, 1986.
9. Curtis R, Hendy PG, Watson DJ, Harris AM, Davies AM, Marshall MJ. A cerate containing cephalonium for the prophylaxis of dry udder infections in dairy cows. Veterinary Record 100, 557–60, 1977.
10. Eberhart RJ. Management of dry cows to reduce mastitis. Journal of Dairy Science 69, 1721–32, 1986.
11. Edmonds MJ, Welsh JA. The prevention of summer mastitis in dry cows by intramammary infusions of ampicillin and cloxacillin. Veterinary Record 104, 554–5, 1979.
12. Harris AM, Marshall MJ, Curtis R, Evans JM, Watson DJ. Cephalosporins in the prevention and treatment of mastitis. Veterinary Record 99, 128–9, 1976.
13. Hassan Z, Daniel RCW, O’Boyle D, Frost AJ. Effects of dry cow intramammary therapy on quarter infections in the dry period. Veterinary Record 145, 634–9, 1999.
14. Hehir AF, Feagan JT, Dodson ME. Field evaluation of cloxacillin dry cow therapy in the control of mastitis. In:Proceedings of the 19th International Dairy Conference, New Delhi, India. Pp 142–3, 1974.
15. Hill BM, Small JM. Antibiotic residue release at the beginning of lactation following dry cow therapy. New Zealand Veterinary Journal 33, 105–7, 1985.
16. Hill GN, Keefe TK. Clinical efficacy of cloxacillin in dry-cow mastitis treatment. Modern Veterinary Practice 55, 843–6, 1974.
17. Hogeveen H, Sampimon OC, Hanekamp WJA, Sol J. Monitoring sub-clinical intramammary infections on a low bulk milk somatic cell count farm. In:Chastain JP (ed). Proceedings of the Fourth International Dairy Housing Conference, St. Louis, Missouri. Pp 9–16. American Society of Agricultural Engineers, St Joseph, USA, 1998.
18. Holdaway RJ, Holmes CW, Steffert IJ. A comparison of indirect methods for diagnosis of subclinical intramammary infection in lactating dairy cows. Part 2. The discriminative ability of eight parameters in foremilk from individual quarters of cows. Australian Journal of Dairy Technology 51, 72–8, 1996.
19. Keefe TK. Benzathine cloxacillin as a dry-cow mastitis product. Modern Veterinary Practice 61, 783–5, 1980.
20. Laycock CL, Duganzich D, Woolford MW, Wickham B. Mastitis control and teat preparation. In:Proceedings of the Ruakura Farmers Conference. Pp 62–4. Ruakura Agricultural Research Centre, Hamilton, New Zealand, 1987.
21. Leigh JA. Streptococcus uberis:A permanent barrier to the control of bovine mastitis. Veterinary Journal 157, 225–38, 1999.
22. Leslie KE, Dohoo I, Meek AH. Somatic cell counts in bovine milk. The New Zealand Compendium on Continuing Education for the Practicing Veterinarian, 1(4), 3–11, 1984.
23. McDougall S. Efficacy of two antibiotic treatments in curing clinical and subclinical mastitis in lactating dairy cows. New Zealand Veterinary Journal 46, 226–32, 1998.
24. Meaney WJ, Nash JM. Comparison of two dry cow intramammary treatments. Veterinary Record 100, 492–3, 1977.
25. Nishida M, Mine Y, Kuwahara S. Synergistic activity of ampicillin and cloxacillin. Protective effect of cloxacillin on enzymatic degradation of ampicillin by penicillinase, and the therapeutic activity of mixtures of ampicillin and cloxacillin. Journal of Antibiotics 22, 144–50, 1969.
26. Østeras O. The effect of dry cow therapy -an evaluation of long-acting and short-acting intramammaria. In:Proceedings of the International Symposium on Bovine Mastitis. Pp 129–33. The National Mastitis Council, Madison WI, 1990.
27. Østeras O, Edge VL, Martin SW. Determinants of success or failure in the elimination of major mastitis pathogens in selective dry cow therapy. Journal of Dairy Science 82, 1221–31, 1999.
28. Pankey JW, Barker RM, Twomey A, Duirs G. A note on effectiveness of dry cow therapy in New Zealand dairy herds. New Zealand Veterinary Journal 30, 50–2, 1982.
29. Poutrel B, Serieys F, Lerondelle C. Effet d’un second traitement (ampicilline-cloxacilline) pendant la periode de tarissement sur le niveau d’infection mammaire au velage. Bulletin Mensuel de la Societe Veterinaire Practique de France 67, 659–69, 1983.
30. Sato T, Sawamukai Y, Abe T, Hoshi A, Iwata K, Suzuki T. Treatment and prevention of mastitis in the dry period by the cephalosporin antibiotic cephalonium. Journal ofVeterinary Medicine 778, 28994, 1986.
31. Sheldrake RF, Hoare RJT. The detection of mastitis in individual quarters using electrical conductivity or somatic cell concentration. New Zealand Veterinary Journal 29, 211–3, 1981.
32. Singh KB, Randhawa SS, Nauriyal DC, Sidhu SS. Clinical efficacy of Orbenin LA [cloxacillin] and Ampiclox LC [cloxacillin and ampicillin] in acute mastitis. Indian Journal of Veterinary Medicine 4, 94–6, 1984.
33. Snedecor GW, Cochran WG. Statistical Methods, Pp 223–4. Iowa State University, Iowa, 1967.
34. Storper M, Moshe BB, Ziv G, Saran A. Experiments with three new intramammary antibiotic combination products for the treatment of subclinical mastitis in lactating cows. Refuah Veterinarith 38, 154–66, 1981.
35. Watkins JH, Buswell JF, Hutchinson I. The treatment of clinical mastitis with a combination of ampicillin and cloxacillin. Veterinary Record 13, 289–90, 1975.
36. Williamson JH, Woolford MW, Day AM. The prophylactic effect of a dry-cow antibiotic against Streptococcus uberis. New Zealand Veterinary Journal 43, 228–34, 1995.
37. Woolford MW, Hook IS, Eden MT, Joe AK. The “SAMM Plan”, a Seasonal Approach to Managing Mastitis. In:Saran A, Soback S (eds). Proceedings of the 3rd IDF International Mastitis Seminar S4, 59–63, 1995.
38. Ziv G, Storper M, Saran A. Comparative efficacy of three antibiotic products for the treatment and prevention of subclinical mastitis during the dry period. The Veterinary Quarterly 2, 74–9, 1981.